Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 29, 2026 Filed Sep 2, 2026 00:16 UTC |
Zelnick Kaufman BethChief Legal Officer
|
Tax withholdingCommon Stock | 8,424 | $8.30 | $69,919.20 |
DisclosureSEC source: 0001213900-26-096383 · ownership.xml · nonDerivative · entry 1 Zelnick Kaufman Beth · CIK 0002004480 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,684 Read SEC document |
| August 29, 2026 Filed Sep 2, 2026 00:20 UTC |
Blum SusanChief Financial Officer
|
Tax withholdingCommon Stock | 8,424 | $8.30 | $69,919.20 |
DisclosureSEC source: 0001213900-26-096386 · ownership.xml · nonDerivative · entry 1 Blum Susan · CIK 0001792253 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,315 Read SEC document |
| August 29, 2026 Filed Sep 2, 2026 00:18 UTC |
Hurlburt ElizabethChief Operating Officer
|
Tax withholdingCommon Stock | 8,076 | $8.30 | $67,030.80 |
DisclosureSEC source: 0001213900-26-096385 · ownership.xml · nonDerivative · entry 1 Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,463 Read SEC document |
| February 04, 2026 Filed Feb 7, 2026 02:30 UTC |
Zelnick Kaufman BethChief Legal Officer
|
GrantCommon Stock | 36,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-013408 · ownership.xml · nonDerivative · entry 1 Zelnick Kaufman Beth · CIK 0002004480 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,108 F1 · price: Represents the achievement of performance stock units ("PSUs") upon the determination of the Compensation Committee of the Issuer that the performance conditions specific to the first of three performance periods were met with respect to the PSUs granted to the Reporting Person on January 2, 2025. The PSUs are subject to vesting upon satisfaction of time-based vesting conditions by the Reporting Person. Read SEC document |
| February 04, 2026 Filed Feb 7, 2026 02:30 UTC |
Hurlburt ElizabethChief Operating Officer
|
GrantCommon Stock | 36,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-013407 · ownership.xml · nonDerivative · entry 1 Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 278,539 F1 · price: Represents the achievement of performance stock units ("PSUs") upon the determination of the Compensation Committee of the Issuer that the performance conditions specific to the first of three performance periods were met with respect to the PSUs granted to the Reporting Person on January 2, 2025. The PSUs are subject to vesting upon satisfaction of time-based vesting conditions by the Reporting Person. Read SEC document |
| February 04, 2026 Filed Feb 7, 2026 02:30 UTC |
Todisco JosephDirector · Chief Executive Officer
|
GrantCommon Stock | 77,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-013406 · ownership.xml · nonDerivative · entry 1 Todisco Joseph · CIK 0001774807 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 774,749 F1 · price: Represents the achievement of performance stock units ("PSUs") upon the determination of the Compensation Committee of the Issuer that the performance conditions specific to the first of three performance periods were met with respect to the PSUs granted to the Reporting Person on January 2, 2025. The PSUs are subject to vesting upon satisfaction of time-based vesting conditions by the Reporting Person. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 21:30 UTC |
Kaplan MyronDirector
|
GrantCommon Stock | 30,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-008473 · ownership.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 231,487 F1 · price: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 21:30 UTC |
Dillione JanetDirector
|
GrantCommon Stock | 30,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-008476 · ownership.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,926 F1 · price: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 21:30 UTC |
Stewart Robert ADirector
|
GrantCommon Stock | 30,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-008477 · ownership.xml · nonDerivative · entry 1 Stewart Robert A · CIK 0001476493 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,453 F1 · price: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 02:30 UTC |
Lefkowitz Steven WDirector
|
GrantCommon Stock | 30,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-008474 · ownership.xml · nonDerivative · entry 1 Lefkowitz Steven W · CIK 0001313149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,951 F1 · price: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 02:30 UTC |
DUNTON ALAN WDirector
|
GrantCommon Stock | 30,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-008475 · ownership.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,703 F1 · price: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 02:30 UTC |
Duncan Gregory ScottDirector
|
GrantCommon Stock | 30,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-008472 · ownership.xml · nonDerivative · entry 1 Duncan Gregory Scott · CIK 0001831127 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,786 F1 · price: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date. Read SEC document |
| January 23, 2026 Filed Jan 28, 2026 02:30 UTC |
Zelnick Kaufman BethChief Legal Officer
|
Tax withholdingCommon Stock | 8,803 | $7.27 | $63,997.81 |
DisclosureSEC source: 0001213900-26-008480 · ownership.xml · nonDerivative · entry 2 Zelnick Kaufman Beth · CIK 0002004480 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,102 Read SEC document |
| January 23, 2026 Filed Jan 28, 2026 02:30 UTC |
Zelnick Kaufman BethChief Legal Officer
|
GrantCommon Stock | 72,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-008480 · ownership.xml · nonDerivative · entry 1 Zelnick Kaufman Beth · CIK 0002004480 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 241,905 F1 · price: These shares represent restricted stock units granted on 01/23/2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| January 23, 2026 Filed Jan 28, 2026 02:31 UTC |
Blum SusanChief Financial Officer
|
Tax withholdingCommon Stock | 9,767 | $7.27 | $71,006.09 |
DisclosureSEC source: 0001213900-26-008482 · ownership.xml · nonDerivative · entry 2 Blum Susan · CIK 0001792253 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,739 Read SEC document |
| January 23, 2026 Filed Jan 28, 2026 02:31 UTC |
Blum SusanChief Financial Officer
|
GrantCommon Stock | 72,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-008482 · ownership.xml · nonDerivative · entry 1 Blum Susan · CIK 0001792253 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,506 F1 · price: These shares represent restricted stock units granted on 01/23/2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| January 23, 2026 Filed Jan 28, 2026 02:30 UTC |
Hurlburt ElizabethChief Operating Officer
|
Tax withholdingCommon Stock | 10,778 | $7.27 | $78,356.06 |
DisclosureSEC source: 0001213900-26-008479 · ownership.xml · nonDerivative · entry 2 Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,533 Read SEC document |
| January 23, 2026 Filed Jan 28, 2026 02:30 UTC |
Hurlburt ElizabethChief Operating Officer
|
GrantCommon Stock | 93,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-008479 · ownership.xml · nonDerivative · entry 1 Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 253,311 F1 · price: These shares represent restricted stock units granted on 01/23/2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| January 23, 2026 Filed Jan 28, 2026 02:30 UTC |
Todisco JosephDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 27,306 | $7.27 | $198,514.62 |
DisclosureSEC source: 0001213900-26-008478 · ownership.xml · nonDerivative · entry 2 Todisco Joseph · CIK 0001774807 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 697,593 Read SEC document |
| January 23, 2026 Filed Jan 28, 2026 02:30 UTC |
Todisco JosephDirector · Chief Executive Officer
|
GrantCommon Stock | 225,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-008478 · ownership.xml · nonDerivative · entry 1 Todisco Joseph · CIK 0001774807 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 724,899 F1 · price: These shares represent restricted stock units granted on 01/23/2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| January 21, 2026 Filed Jan 22, 2026 21:30 UTC |
Dillione JanetDirector
|
SaleCommon Stock | 10,000 | $6.88 | $68,800.00 |
DisclosureSEC source: 0001213900-26-006876 · ownership.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,473 F1 · price: This transaction was executed in multiple trades at prices ranging from $6.85 to $6.90, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected Read SEC document |
| January 17, 2026 Filed Jan 20, 2026 14:28 UTC |
Todisco JosephDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 22,665 | $6.78 | $153,668.70 |
DisclosureSEC source: 0001213900-26-005425 · ownership.xml · nonDerivative · entry 3 Todisco Joseph · CIK 0001774807 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 498,999 Read SEC document |
| January 16, 2026 Filed Jan 20, 2026 14:28 UTC |
Todisco JosephDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative | 29,585 | $0.00 Strike: $3.38 | $0.00 |
DisclosureSEC source: 0001213900-26-005425 · ownership.xml · derivative · entry 4 Todisco Joseph · CIK 0001774807 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 411,245 Underlying: Common Stock · 29,585 shares Expires 2032-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on 5/10/2022. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date. Read SEC document |
| January 16, 2026 Filed Jan 20, 2026 14:28 UTC |
Todisco JosephDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 29,585 | $3.38 | $99,997.30 |
DisclosureSEC source: 0001213900-26-005425 · ownership.xml · nonDerivative · entry 2 Todisco Joseph · CIK 0001774807 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 521,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The Reporting Person acquired stock through the exercise of options granted on 5/10/2022. The Reporting Person paid the exercise price in cash. No sales of stock were made. Read SEC document |
| January 12, 2026 Filed Jan 15, 2026 02:30 UTC |
Lefkowitz Steven WDirector
|
Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative | 15,000 | $0.00 Strike: $5.63 | $0.00 |
DisclosureSEC source: 0001213900-26-004470 · ownership.xml · derivative · entry 4 Lefkowitz Steven W · CIK 0001313149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2030-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These stock options, representing a right to purchase 15,000 shares of Common Stock, were granted on 02/25/2020. These stock options are fully vested. Read SEC document |
| January 12, 2026 Filed Jan 15, 2026 02:30 UTC |
Lefkowitz Steven WDirector
|
Exercise / conversionCommon Stock | 15,000 | $5.63 | $84,450.00 |
DisclosureSEC source: 0001213900-26-004470 · ownership.xml · nonDerivative · entry 1 Lefkowitz Steven W · CIK 0001313149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The Reporting Person acquired stock through the exercise of options granted on 02/25/2020. The Reporting Person paid the exercise price in cash. No sales of stock were made. Read SEC document |
| January 12, 2026 Filed Jan 20, 2026 14:28 UTC |
Hurlburt ElizabethChief Operating Officer
|
Tax withholdingCommon Stock | 5,794 | $7.15 | $41,427.10 |
DisclosureSEC source: 0001213900-26-005426 · ownership.xml · nonDerivative · entry 1 Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,301 F1 · date: This transaction is being reported late due to an inadvertent administrative error. Read SEC document |
| January 12, 2026 Filed Jan 20, 2026 14:28 UTC |
Todisco JosephDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 17,417 | $7.15 | $124,531.55 |
DisclosureSEC source: 0001213900-26-005425 · ownership.xml · nonDerivative · entry 1 Todisco Joseph · CIK 0001774807 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 492,079 F1 · date: This transaction is being reported late due to an inadvertent administrative error. Read SEC document |
| January 08, 2026 Filed Jan 16, 2026 02:30 UTC |
Seckler Michael DavidChief Commercial Officer
|
GrantCommon Stock | 133,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-004857 · ownership.xml · nonDerivative · entry 1 Seckler Michael David · CIK 0002105167 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,156 F1 · price: These Restricted Stock Units were granted on 01/08/2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date. Read SEC document |
| January 02, 2026 Filed Jan 7, 2026 02:30 UTC |
Zelnick Kaufman BethChief Legal Officer
|
Tax withholdingCommon Stock | 11,333 | $12.16 | $137,809.28 |
DisclosureSEC source: 0001213900-26-001937 · ownership.xml · nonDerivative · entry 1 Zelnick Kaufman Beth · CIK 0002004480 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,085 Read SEC document |
| January 02, 2026 Filed Jan 7, 2026 02:30 UTC |
Hurlburt ElizabethChief Operating Officer
|
Tax withholdingCommon Stock | 10,895 | $12.16 | $132,483.20 |
DisclosureSEC source: 0001213900-26-001938 · ownership.xml · nonDerivative · entry 1 Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,095 Read SEC document |
| December 30, 2025 Filed Jan 3, 2026 02:30 UTC |
DUNTON ALAN WDirector
|
Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative | 20,000 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0001213900-26-000712 · ownership.xml · derivative · entry 3 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2032-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options were granted on 2/22/2022. These options are fully vested. Read SEC document |
| December 30, 2025 Filed Jan 3, 2026 02:30 UTC |
DUNTON ALAN WDirector
|
SaleCommon Stock | 20,000 | $13.00 | $260,000.00 |
DisclosureSEC source: 0001213900-26-000712 · ownership.xml · nonDerivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,250 Read SEC document |
| December 30, 2025 Filed Jan 3, 2026 02:30 UTC |
DUNTON ALAN WDirector
|
Exercise / conversionCommon Stock | 20,000 | $4.03 | $80,600.00 |
DisclosureSEC source: 0001213900-26-000712 · ownership.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2025 Filed Dec 20, 2025 02:30 UTC |
Todisco JosephDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative | 30,000 | $0.00 Strike: $4.43 | $0.00 |
DisclosureSEC source: 0001213900-25-124063 · ownership.xml · derivative · entry 3 Todisco Joseph · CIK 0001774807 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 370,000 Underlying: Common Stock · 30,000 shares Expires 2033-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on 01/14/2023. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| December 18, 2025 Filed Dec 20, 2025 02:30 UTC |
Todisco JosephDirector · Chief Executive Officer
|
SaleCommon Stock | 30,000 | $12.00 | $360,000.00 |
DisclosureSEC source: 0001213900-25-124063 · ownership.xml · nonDerivative · entry 2 Todisco Joseph · CIK 0001774807 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 509,496 F1 · price: This transaction was executed in multiple trades at prices ranging from $12.00 to $12.02, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| December 18, 2025 Filed Dec 20, 2025 02:30 UTC |
Todisco JosephDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 30,000 | $4.43 | $132,900.00 |
DisclosureSEC source: 0001213900-25-124063 · ownership.xml · nonDerivative · entry 1 Todisco Joseph · CIK 0001774807 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 539,496 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 02:38 UTC |
Lefkowitz Steven WDirector
|
SaleCommon Stock | 40,000 | $11.88 | $475,200.00 |
DisclosureSEC source: 0001213900-25-120296 · ownership.xml · nonDerivative · entry 1 Lefkowitz Steven W · CIK 0001313149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,498 F1 · price: This transaction was executed in multiple trades at prices ranging from $11.87 to $11.92, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 08:38 UTC |
Dillione JanetDirector
|
Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative | 15,000 | $0.00 Strike: $5.63 | $0.00 |
DisclosureSEC source: 0001213900-25-120378 · ownership.xml · derivative · entry 5 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2030-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on 02/25/2020. These options are fully vested. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 08:38 UTC |
Dillione JanetDirector
|
Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative | 19,000 | $0.00 Strike: $9.55 | $0.00 |
DisclosureSEC source: 0001213900-25-120378 · ownership.xml · derivative · entry 4 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,000 shares Expires 2026-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on 02/21/2016. These options are fully vested. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 08:38 UTC |
Dillione JanetDirector
|
SaleCommon Stock | 34,000 | $12.00 | $408,000.00 |
DisclosureSEC source: 0001213900-25-120378 · ownership.xml · nonDerivative · entry 3 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,473 F1 · price: This transaction was executed in multiple trades at prices ranging from $12.00 to $12.02, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 08:38 UTC |
Dillione JanetDirector
|
Exercise / conversionCommon Stock | 15,000 | $5.63 | $84,450.00 |
DisclosureSEC source: 0001213900-25-120378 · ownership.xml · nonDerivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 08:38 UTC |
Dillione JanetDirector
|
Exercise / conversionCommon Stock | 19,000 | $9.55 | $181,450.00 |
DisclosureSEC source: 0001213900-25-120378 · ownership.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:30 UTC |
Dillione JanetDirector
|
Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative | 19,323 | $0.00 Strike: $3.55 | $0.00 |
DisclosureSEC source: 0001213900-25-118433 · ownership.xml · derivative · entry 7 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 19,323 shares Expires 2034-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on 03/05/2024. These options are fully vested. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:30 UTC |
Dillione JanetDirector
|
Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative | 15,124 | $0.00 Strike: $4.43 | $0.00 |
DisclosureSEC source: 0001213900-25-118433 · ownership.xml · derivative · entry 6 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,124 shares Expires 2033-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on 01/14/2023. These options are fully vested. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:30 UTC |
Dillione JanetDirector
|
Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative | 12,210 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0001213900-25-118433 · ownership.xml · derivative · entry 5 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,210 shares Expires 2032-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options were granted on 02/22/2022. These options are fully vested. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:30 UTC |
Dillione JanetDirector
|
SaleCommon Stock | 46,657 | $10.00 | $466,570.00 |
DisclosureSEC source: 0001213900-25-118433 · ownership.xml · nonDerivative · entry 4 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,473 Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:30 UTC |
Dillione JanetDirector
|
Exercise / conversionCommon Stock | 19,323 | $3.55 | $68,596.65 |
DisclosureSEC source: 0001213900-25-118433 · ownership.xml · nonDerivative · entry 3 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:30 UTC |
Dillione JanetDirector
|
Exercise / conversionCommon Stock | 15,124 | $4.43 | $66,999.32 |
DisclosureSEC source: 0001213900-25-118433 · ownership.xml · nonDerivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:30 UTC |
Dillione JanetDirector
|
Exercise / conversionCommon Stock | 12,210 | $4.03 | $49,206.30 |
DisclosureSEC source: 0001213900-25-118433 · ownership.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.